NCT02170207View on ClinicalTrials.gov

Takepron Intravenous 30 mg Specified Drug-use Survey [Acute Stress Ulcer and Acute Gastric Mucosal Lesions]

CompletedOBSERVATIONAL
Enrollment

63

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Acute Stress Ulcer and Acute Gastric Mucosal Lesions
Interventions
DRUG

Lansoprazole

Lansoprazole 30 mg injection

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT02170207 - Takepron Intravenous 30 mg Specified Drug-use Survey [Acute Stress Ulcer and Acute Gastric Mucosal Lesions] | Biotech Hunter | Biotech Hunter